SCORE

62

NUVA: NuVasive, Inc. is a Buy


The current rating for NUVA is 62, which is 24% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.